Skip to main content
. 2026 Jun 17;14:1819814. doi: 10.3389/fpubh.2026.1819814

Table 2.

Distribution of serological markers in the study group.

Hepatitis B markers (combinatorial serological profile) Prevalence (N = 2,533)
n % 95% CI
HBsAg only 11 0.4 0.2–0.8
Anti-HBs only 435 17.2 15.8–18.7
Anti-HBc only 100 3.9 3.3–4.8
HBsAg, anti-HBs 2 0.1 0.0–0.3
HBsAg, anti-HBc 10 0.4 0.2–0.7
HBsAg, anti-HBs, anti-HBc 2 0.1 0.0–0.3
Anti-HBs, anti-HBc 108 4.3 3.5–5.1
Any of the following: HBsAg, anti-HBs, anti-HBc 668 26.4 24.7–28.1
The aforementioned markers are absent 1,865 73.6 71.9–75.3